These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 16279687)

  • 1. [Regulation of fibroblast growth factor 23 in metabolic bone diseases].
    Imanishi Y
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():486-91. PubMed ID: 16279687
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fibroblast growth factor 23, a new phosphaturic factor in hypophosphatemic rickets/osteomalacia].
    Nishizawa Y; Imanishi Y
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():469-74. PubMed ID: 16279684
    [No Abstract]   [Full Text] [Related]  

  • 3. [X-linked hypophosphatemic vitamin D resistant rickets: Pathogenesis, pathophysiology, and therapy].
    Tanaka H
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():556-61. PubMed ID: 16523954
    [No Abstract]   [Full Text] [Related]  

  • 4. FGF23 and disorders of phosphate homeostasis.
    Yu X; White KE
    Cytokine Growth Factor Rev; 2005 Apr; 16(2):221-32. PubMed ID: 15863037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [X-linked hypophosphatemic rickets].
    Tanaka H
    Nihon Rinsho; 2006 Jun; Suppl 2():120-5. PubMed ID: 16817365
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathogenic role of Fgf23 in Hyp mice.
    Liu S; Zhou J; Tang W; Jiang X; Rowe DW; Quarles LD
    Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E38-49. PubMed ID: 16449303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization.
    Quarles LD
    Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E1-9. PubMed ID: 12791601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [From gene to disease; hypophosphataemic rickets and the PHEX gene].
    Jansen M; van Dael CM; Verrijn Stuart AA; van der Hout AH; Rump P
    Ned Tijdschr Geneeskd; 2006 Jun; 150(25):1390-4. PubMed ID: 16841587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular biology in regulation of kidney functions: FGF23 (fibroblast growth factor 23)].
    Tanaka H
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():322-6. PubMed ID: 16523910
    [No Abstract]   [Full Text] [Related]  

  • 10. The PEX gene: its role in X-linked rickets, osteomalacia, and bone mineral metabolism.
    Rowe PS
    Exp Nephrol; 1997; 5(5):355-63. PubMed ID: 9386970
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
    Jonsson KB; Zahradnik R; Larsson T; White KE; Sugimoto T; Imanishi Y; Yamamoto T; Hampson G; Koshiyama H; Ljunggren O; Oba K; Yang IM; Miyauchi A; Econs MJ; Lavigne J; Jüppner H
    N Engl J Med; 2003 Apr; 348(17):1656-63. PubMed ID: 12711740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endocrine diseases accompanied by hypophosphatemia or hyperphosphatemia].
    Nakayama K
    Nihon Rinsho; 2006 Sep; Suppl 3():542-52. PubMed ID: 17022606
    [No Abstract]   [Full Text] [Related]  

  • 13. [Autosomal dominant hypophosphatemic rickets/osteomalacia].
    Tanaka H
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():529-33. PubMed ID: 16279695
    [No Abstract]   [Full Text] [Related]  

  • 14. A familial disorder with low bone density and renal phosphate wasting.
    Grondel IM; van der Deure J; Zanen AL; Dogger M; van den Heuvel LP
    Eur J Intern Med; 2009 Sep; 20(5):503-8. PubMed ID: 19712854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 23 and its receptors.
    Yu X; White KE
    Ther Apher Dial; 2005 Aug; 9(4):308-12. PubMed ID: 16076372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic advances, biochemical and clinical features and critical approach to treatment of patients with X-linked hypophosphatemic rickets.
    Baroncelli GI; Bertelloni S; Sodini F; Galli L; Vanacore T; Fiore L; Saggese G
    Pediatr Endocrinol Rev; 2004 Jun; 1(4):361-79. PubMed ID: 16437029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrous dysplasia, phosphate wasting and fibroblast growth factor 23.
    Imel EA; Econs MJ
    Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():434-9. PubMed ID: 17982392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
    Kida Y
    N Engl J Med; 2003 Jul; 349(5):505-6; author reply 505-6. PubMed ID: 12890852
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of the transgenic approach to determine the role of DMP1 in phosphate regulation.
    Lu Y; Liu S; Xie Y; Yu S; Quarles L; Bonewald LF; Feng JQ
    J Musculoskelet Neuronal Interact; 2007; 7(4):309. PubMed ID: 18094487
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fibroblast growth factor 23 (FGF 23): a new fosfaturic hormone?].
    Negri AL
    Nefrologia; 2003; 23(6):478-81. PubMed ID: 15002780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.